News
Dynamic landscape of peripheral blood immunity during human pregnancy FAYETTEVILLE, GA, UNITED STATES, April 16, 2025 /EINPresswire / -- Th ...
This is particularly true when dying or dead cells are engulfed by antigen-presenting cells, such as dendritic cells (DCs ... of associated antigens on MHC class I molecules.
NGS, next-generation sequencing; DCs, dendritic cells; PBMCs, peripheral blood mononuclear cells ... Efficacy of T-cell induction by long peptide binding to MHC II (Case Report) Building on the ...
SLE plasma also induced the expression of MHC class I, CD38, and CD123 on monocytes ... Conclusions: The pathogenic role of type I IFN is suggested by the induction of cell surface markers for ...
New research zeroes in on a unique group of immune cells that could transform how we treat—and possibly prevent—severe food ...
2d
AZoLifeSciences on MSNTolerogenic Dendritic Cells in Gut Prevent Allergic Reactions to FoodThe immune system must be able to rapidly target invaders such as viruses while avoiding innocuous stimuli, or allergies may develop.
A study led by the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), in collaboration with the Instituto ...
The immune system must be able to quickly attack invaders like viruses, while also ignoring harmless stimuli, or allergies can result. Immune cells are known to ignore or "tolerate" molecules found on ...
Tolerogenic dendritic cells in the intestines are shown to reduce the immune responses caused by exposure to food proteins.
including miniature microscopes that captured single-cell resolution in live animals. The study shows that memories are stored in dendritic compartments: When one memory forms, the affected ...
This subcellular compartment is where antigens are trimmed (generating an antigen version called an epitope) and loaded onto MHC-I molecules ... for stimulating T cells and generating effective ...
Apr. 11, 2025 — A multi-institutional team developed a chimeric antigen receptor (CAR) T cell-based strategy for specifically targeting AML cells in patients who relapsed following other treatments.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results